Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/16/24 16:36 | 1/16/24 | AVDL | Health | Drug | Pharmaceutical Preparations | McHugh Thomas S | L2 | O | CFO | 2 | P | 58 | 14.48 | 0 | 4 | 5 | 81 | D | ||||||||||||||
8/11/23 16:00 | 8/10/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Glass Geoffrey Michael | L2 | D | 1 | P | 188 | 13.40 | 0 | 14 | 13 | 125 | I | |||||||||||||||
8/10/23 18:45 | 8/10/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Divis Gregory J | L2 | DO | CEO | 1 | P | 132 | 13.20 | 0 | 10 | 7 | 159 | D | ||||||||||||||
5/19/23 16:16 | 5/18/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Ende Eric J | L2 | D | 1 | P | 181 | 13.93 | 0 | 13 | 8 | 168 | D | |||||||||||||||
5/10/23 16:12 | 5/9/23 | AVDL | Health | Drug | Pharmaceutical Preparations | Palczuk Linda | L2 | D | 1 | P | 37 | 14.76 | 0 | 3 | 5 | 52 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |